Similar articles for PMID: 8871537

Year	Number of Results
1992	1
1993	3
1994	2
1995	11
1996	9
1997	6
1998	13
1999	6
2000	4
2001	6
2002	1
2003	3
2004	1
2005	3
2006	2
2007	1
2008	1
2009	2
2010	3
2011	1
2014	3
2015	4
2016	4
2017	3
2018	3
2019	1
2021	2
2024	0

1

CD44 exon 6 expression as a possible early prognostic factor in primary node negative breast carcinoma.

Guriec N, Marcellin L, Gairard B, Caldéroli H, Wilk A, Renaud R, Bergerat JP, Oberling F. Guriec N, et al. Clin Exp Metastasis. 1996 Oct;14(5):434-9. doi: 10.1007/BF00128959. Clin Exp Metastasis. 1996. PMID: 8871537

2

CD44 isoforms with exon v6 and metastasis of primary N0M0 breast carcinomas.

Guriec N, Gairard B, Marcellin L, Wilk A, Caldéroli H, Renaud R, Bergerat JP, Oberling F. Guriec N, et al. Breast Cancer Res Treat. 1997 Jul;44(3):261-8. doi: 10.1023/a:1005717519931. Breast Cancer Res Treat. 1997. PMID: 9266106

3

CD44 expression patterns in breast and colon tumors: a PCR-based study of splice variants.

Rodriguez C, Monges G, Rouanet P, Dutrillaux B, Lefrançois D, Theillet C. Rodriguez C, et al. Int J Cancer. 1995 Oct 20;64(5):347-54. doi: 10.1002/ijc.2910640512. Int J Cancer. 1995. PMID: 7591309

4

Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer.

Dall P, Heider KH, Sinn HP, Skroch-Angel P, Adolf G, Kaufmann M, Herrlich P, Ponta H. Dall P, et al. Int J Cancer. 1995 Feb 8;60(4):471-7. doi: 10.1002/ijc.2910600408. Int J Cancer. 1995. PMID: 7530237

5

A CD44 variant exon 6 epitope as a prognostic indicator in breast cancer.

Schumacher U, Horny HP, Horst HA, Herrlich P, Kaiserling E. Schumacher U, et al. Eur J Surg Oncol. 1996 Jun;22(3):259-61. doi: 10.1016/s0748-7983(96)80014-x. Eur J Surg Oncol. 1996. PMID: 8654608

6

The expression of variant exon v7-v8 CD44 antigen in relation to lymphatic metastasis of human breast cancer.

Kinoshita J, Haga S, Shimizu T, Imamura H, Watanabe O, Kajiwara T. Kinoshita J, et al. Breast Cancer Res Treat. 1999 Jan;53(2):177-83. doi: 10.1023/a:1006130601575. Breast Cancer Res Treat. 1999. PMID: 10326795

7

CD44 variant exon epitopes in primary breast cancer and length of survival.

Kaufmann M, Heider KH, Sinn HP, von Minckwitz G, Ponta H, Herrlich P. Kaufmann M, et al. Lancet. 1995 Mar 11;345(8950):615-9. doi: 10.1016/s0140-6736(95)90521-9. Lancet. 1995. PMID: 7534855

8

Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44.

Sinn HP, Heider KH, Skroch-Angel P, von Minckwitz G, Kaufmann M, Herrlich P, Ponta H. Sinn HP, et al. Breast Cancer Res Treat. 1995;36(3):307-313. doi: 10.1007/BF00713402. Breast Cancer Res Treat. 1995. PMID: 8573713

9

CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis.

Sosulski A, Horn H, Zhang L, Coletti C, Vathipadiekal V, Castro CM, Birrer MJ, Nagano O, Saya H, Lage K, Donahoe PK, Pépin D. Sosulski A, et al. PLoS One. 2016 Jun 2;11(6):e0156595. doi: 10.1371/journal.pone.0156595. eCollection 2016. PLoS One. 2016. PMID: 27253518 Free PMC article.

10

CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer.

Friedrichs K, Franke F, Lisboa BW, Kügler G, Gille I, Terpe HJ, Hölzel F, Maass H, Günthert U. Friedrichs K, et al. Cancer Res. 1995 Nov 15;55(22):5424-33. Cancer Res. 1995. PMID: 7585612

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

98 results

Results by year